ID KMST-6/T AC CVCL_2999 DR BTO; BTO_0002040 DR JCRB; JCRB0434 DR Wikidata; Q54900191 RX PubMed=1537630; RX PubMed=8601579; RX PubMed=9290701; CC Population: Japanese. CC Characteristics: Tumorigenic. Established from 2nd-passage tumors obtained in nude mice by transplanting one of the primary tumors produced by subcutaneous inoculation of KMST-6 cells into nude mice. CC Doubling time: 37 +- 4.6 hours (Note=In 10% FBS), 47 +- 2.9 hours (Note=In 1% FBS) (PubMed=1537630). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (from parent cell line). CC Transformant: NCIt; C129640; Cobalt-60 gamma radiation. CC Discontinued: JCRB; JCRB0434; true. CC Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323. CC Cell type: Fibroblast; CL=CL_0000057. OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_2998 ! KMST-6 SX Female AG 9FW CA Transformed cell line DT Created: 04-04-12; Last updated: 19-12-24; Version: 20 // RX PubMed=1537630; DOI=10.1002/ijc.2910500426; RA Mihara K., Bai L., Kano Y., Miyazaki M., Namba M.; RT "Malignant transformation of human fibroblasts previously immortalized RT with 60Co gamma rays."; RL Int. J. Cancer 50:639-643(1992). // RX PubMed=8601579; DOI=10.1007/BF01209654; RA Jahan I., Iijima M., Kondo T., Namba M.; RT "Effects of okadaic acid on cell growth, anchorage-independent growth, RT and co-cultures of normal (KMS-6), immortalized (KMST-6), and RT neoplastically transformed (KMST-6T and KMST-6/RAS) human RT fibroblasts."; RL J. Cancer Res. Clin. Oncol. 122:249-253(1996). // RX PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; RA Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., RA Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., RA Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.; RT "Screening the p53 status of human cell lines using a yeast functional RT assay."; RL Mol. Carcinog. 19:243-253(1997). //